Literature DB >> 9432370

Use of DNA fingerprinting in international source case finding during a large outbreak of tuberculosis in The Netherlands.

A Kiers1, A P Drost, D van Soolingen, J Veen.   

Abstract

SETTING: Tuberculosis outbreak in a low prevalence country.
OBJECTIVE: Description of an international source tracing process in which restriction fragment length polymorphism (RFLP) analysis played an essential role.
DESIGN: In 1993 a large scale source tracing process was initiated in Harlingen, a harbour town in the north of The Netherlands, after a child with tuberculous meningitis was reported for which no source could be identified. Traditional contact tracing followed the detection of sources of infection. RFLP was used to map the tuberculosis transmission and identify the source case.
RESULTS: The investigation extended from the north to several places in the west of The Netherlands. In total 6519 persons were screened; there were 276 infections, among which 49 cases of active tuberculosis were identified. RFLP analysis of Mycobacterium tuberculosis isolates from all 28 culture positive patients showed the 'Harlingen' type DNA fingerprint. After 5 months source tracing led to the identification of the source case in the United Kingdom. Up to June 1996 altogether 37 patients (The Netherlands 28; the UK 7; Surinam 1; Morocco 1) were found to have isolates with the Harlingen type DNA pattern. Despite a thorough evaluation, in 5 of the 37 patients no relation to the source case or the outbreak in Harlingen could be established.
CONCLUSION: RFLP typing proved a very useful instrument in guiding the process of international source tracing and contact investigation.

Entities:  

Mesh:

Year:  1997        PMID: 9432370

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  16 in total

1.  Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients.

Authors:  S Lockman; J D Sheppard; C R Braden; M J Mwasekaga; C L Woodley; T A Kenyon; N J Binkin; M Steinman; F Montsho; M Kesupile-Reed; C Hirschfeldt; M Notha; T Moeti; J W Tappero
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  False molecular clusters due to nonrandom association of IS6110 with Mycobacterium tuberculosis.

Authors:  S H Gillespie; A Dickens; T D McHugh
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  High-resolution typing by integration of genome sequencing data in a large tuberculosis cluster.

Authors:  Anita C Schürch; Kristin Kremer; Olaf Daviena; Albert Kiers; Martin J Boeree; Roland J Siezen; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

4.  Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants.

Authors:  Emma Huitric; Jim Werngren; Pontus Juréen; Sven Hoffner
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

5.  Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate.

Authors:  Jim Werngren; Sven E Hoffner
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+ Foxp3+ regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosis.

Authors:  Chaniya Leepiyasakulchai; Lech Ignatowicz; Andrzej Pawlowski; Gunilla Källenius; Markus Sköld
Journal:  Infect Immun       Date:  2012-01-03       Impact factor: 3.441

7.  Preferential deletion events in the direct repeat locus of Mycobacterium tuberculosis.

Authors:  Anita C Schürch; Kristin Kremer; Albert Kiers; Martin J Boeree; Roland J Siezen; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

8.  A Mycobacterium tuberculosis cluster demonstrating the use of genotyping in urban tuberculosis control.

Authors:  Gerard de Vries; Rob A H van Hest; Conny C A Burdo; Dick van Soolingen; Jan H Richardus
Journal:  BMC Infect Dis       Date:  2009-09-08       Impact factor: 3.090

9.  Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.

Authors:  Deneke H Mariam; Yohannes Mengistu; Sven E Hoffner; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  Genomic stability over 9 years of an isoniazid resistant Mycobacterium tuberculosis outbreak strain in Sweden.

Authors:  Linus Sandegren; Ramona Groenheit; Tuija Koivula; Solomon Ghebremichael; Abdolreza Advani; Elsie Castro; Alexandra Pennhag; Sven Hoffner; Jolanta Mazurek; Andrzej Pawlowski; Boris Kan; Judith Bruchfeld; Öjar Melefors; Gunilla Källenius
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.